|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guo C, Zhu K, Sun W, Yang B, Gu W, Luo J,
Peng B and Zheng J: The effect of ZBTB7 on bladder cancer
epithelial-mesenchymal transition. Biochem Biophys Res Commun.
443:1226–1231. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Geng J, Fan J, Ouyang Q, Zhang X, Zhang X,
Yu J, Xu Z, Li Q, Yao X, Liu X and Zheng J: Loss of PPM1A
expression enhances invasion and the epithelial-to-mesenchymal
transition in bladder cancer by activating the TGF-β/Smad signaling
pathway. Oncotarget. 5:5700–5711. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Maeda T, Hobbs RM, Merghoub T, Guernah I,
Zelent A, Cordon-Cardo C, Teruya-Feldstein J and Pandolfi PP: Role
of the proto-oncogene Pokemon in cellular transformation and ARF
repression. Nature. 433:278–285. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang QL, Tian DA and Xu XJ: Depletion of
Pokemon gene inhibits hepatocellular carcinoma cell growth through
inhibition of H-ras. Onkologie. 34:526–531. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Apostolopoulou K, Pateras IS, Evangelou K,
Tsantoulis PK, Liontos M, Kittas C, Tiniakos DG, Kotsinas A,
Cordon-Cardo C and Gorgoulis VG: Gene amplification is a relatively
frequent event leading to ZBTB7A (Pokemon) overexpression in
non-small cell lung cancer. J Pathol. 213:294–302. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Aggarwal A, Hunter WJ III, Aggarwal H,
Silva ED, Davey MS, Murphy RF and Agrawal DK: Expression of
leukemia/lymphoma-related factor (LRF/ZBTB7) in human breast
carcinoma and other cancers. Exp Mol Pathol. 89:140–148. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rovin RA and Winn R: Pokemon expression in
malignant glioma: An application of bioinformatics methods.
Neurosurg Focus. 19:E82005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qu H, Qu D, Chen F, Zhang Z, Liu B and Liu
H: ZBTB7 overexpression contributes to malignancy in breast cancer.
Cancer Invest. 28:672–678. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Maeda T, Merghoub T, Hobbs RM, Dong L,
Maeda M, Zakrzewski J, van den Brink MR, Zelent A, Shigematsu H,
Akashi K, et al: Regulation of B versus T lymphoid lineage fate
decision by the proto-oncogene LRF. Science. 316:860–866. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang L, Siu MK, Wong OG, Tam KF, Lam EW,
Ngan HY, Le XF, Wong ES, Chan HY and Cheung AN: Overexpression of
proto-oncogene FBI-1 activates membrane type 1-matrix
metalloproteinase in association with adverse outcome in ovarian
cancers. Mol Cancer. 9:3182010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shi SR, Key ME and Kalra KL: Antigen
retrieval in formalin-fixed, paraffin-embedded tissues: An
enhancement method for immunohistochemical staining based on
microwave oven heating of tissue sections. J Histochem Cytochem.
39:741–748. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao ZH, Wang SF, Yu L, Wang J, Chang H,
Yan WL, Fu K and Zhang J: Expression of transcription factor
Pokemon in non-small cell lung cancer and its clinical
significance. Chin Med J (Engl). 121:445–449. 2008.PubMed/NCBI
|
|
17
|
Sobin LH and Fleming ID: TNM
classification of malignant tumors, fifth edition (1997). Union
Internationale Contre le Cancer and the American Joint Committee on
Cancer. Cancer. 80:1803–1804. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
World Health Organization Classification
of Tumours: Pathology and Genetics of Tumours of the Urinary
Systemand Male Genital Organs. Eble JN, Sauter G, Epstein JI and
Sesterhenn IA: IARC Press; Lyon: 2004
|
|
19
|
Chavan S, Bray F, Lortet-Tieulent J,
Goodman M and Jemal A: International variations in bladder cancer
incidence and mortality. Eur Urol. 66:59–73. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Scarpato KR, Morgans AK and Moses KA:
Optimal management of muscle-invasive bladder cancer-a review. Res
Rep Urol. 7:143–151. 2015.PubMed/NCBI
|
|
21
|
Yeh CM, Chen PC, Hsieh HY, Jou YC, Lin CT,
Tsai MH, Huang WY, Wang YT, Lin RI, Chen SS, et al: Methylomics
analysis identifies ZNF671 as an epigenetically repressed novel
tumor suppressor and a potential non-invasive biomarker for the
detection of urothelial carcinoma. Oncotarget. 6:29555–29572. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nakashima M, Matsui Y, Kobayashi T, Saito
R, Hatahira S, Kawakami K, Nakamura E, Nishiyama H and Ogawa O:
Urine CXCL1 as a biomarker for tumor detection and outcome
prediction in bladder cancer. Cancer Biomark. 15:357–364. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kelly KF and Daniel JM: POZ for
effect-POZ-ZF transcription factors in cancer and development.
Trends Cell Biol. 16:578–587. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Stogios PJ, Chen L and Privé GG: Crystal
structure of the BTB domain from the LRF/ZBTB7 transcriptional
regulator. Protein Sci. 16:336–342. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen WY, Zeng X, Carter MG, Morrell CN,
Yen Chiu RW, Esteller M, Watkins DN, Herman JG, Mankowski JL and
Baylin SB: Heterozygous disruption of Hic1 predisposes mice to a
gender-dependent spectrum of malignant tumors. Nat Genet.
33:197–202. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao ZH, Wang SF, Yu L, Wang J, Chang H,
Yan WL, Zhang J and Fu K: Overexpression of Pokemon in non-small
cell lung cancer and foreshowing tumor biological behavior as well
as clinical results. Lung Cancer. 62:113–119. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jiao W, Liu F, Tang FZ, Lan J, Xiao RP,
Chen XZ, Ye HL and Cai YL: Expression of the Pokemon proto-oncogene
in nasopharyngeal carcinoma cell lines and tissues. Asian Pac J
Cancer Prev. 14:6315–6319. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao GT, Yang LJ, Li XX, Cui HL and Guo R:
Expression of the proto-oncogene Pokemon in colorectal
cancer-inhibitory effects of an siRNA. Asian Pac J Cancer Prev.
14:4999–5005. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li W, Kidiyoor A, Hu Y, Guo C, Liu M, Yao
X, Zhang Y, Peng B and Zheng J: Evaluation of transforming growth
factor-β1 suppress Pokemon/epithelial-mesenchymal transition
expression in human bladder cancer cells. Tumour Biol.
36:1155–1162. 2015. View Article : Google Scholar : PubMed/NCBI
|
